Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Portugal launches COPD detection programme

This article was originally published in Clinica

Executive Summary

Portugal has begun to roll out a national chronic obstructive pulmonary disorder (COPD) early detection programme. The initiative features the provision of spirometry and other diagnostic equipment in mobile units that are designed to complement local primary care provision. The aim of the programme is to improve early detection rates and improve care outcomes; until now, COPD diagnosis has only been offered through hospital referral. The condition affects more than 5% of the Portuguese population, according to the health ministry. The programme was launched in Portugal's northern region; it is scheduled to be extended across the Lisbon North area by the end of this month.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043501

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel